Home/Filings/4/0001179110-11-006462
4//SEC Filing

Smith Scott E 4

Accession 0001179110-11-006462

CIK 0001222244other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 2:55 PM ET

Size

17.4 KB

Accession

0001179110-11-006462

Insider Transaction Report

Form 4
Period: 2011-04-12
Transactions
  • Award

    Common Stock, $0.00001 par value

    2011-04-12$0.53/sh+9,524$5,000148,883 total
Holdings
  • Stock Options

    Exercise: $1.00Exp: 2015-08-12Common stock, $0.00001 par value (1,000 underlying)
    1,000
  • Warrants

    Exercise: $1.30From: 2009-11-12Exp: 2012-11-12Common stock, $0.00001 par value (20,000 underlying)
    20,000
  • Warrants

    Exercise: $0.70Exp: 2012-12-31Common Stock, $0.00001 par value (7,000 underlying)
    7,000
  • Stock Options

    Exercise: $7.00Exp: 2013-05-30Common Stock, $0.00001 par value (3,000 underlying)
    3,000
  • Stock Options

    Exercise: $0.85Exp: 2016-03-03Common stock, $0.00001 par value (20,000 underlying)
    20,000
  • Warrants

    Exercise: $1.30Exp: 2013-07-12Common stock, $0.00001 par value (32,475 underlying)
    32,475
  • Stock options

    Exercise: $1.50Exp: 2016-09-29Common stock, $0.00001 par value (30,000 underlying)
    30,000
  • Warrants

    Exercise: $1.30Exp: 2014-01-07Common stock, $0.00001 par value (10,000 underlying)
    10,000
  • Options

    Exercise: $1.72Exp: 2017-08-10Common stock $0.00001 par value (14,535 underlying)
    14,535
  • Stock Options

    Exercise: $1.25Exp: 2016-08-11Common Stock, $0.00001 par value (1,000 underlying)
    1,000
Footnotes (3)
  • [F1]Currently exercisable.
  • [F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
  • [F3]Shares issued in lieu of cash for directors' fees as approved by the issuer's Board of Directors, which are exempt under Section 16b-3(d).

Issuer

ProUroCare Medical Inc.

CIK 0001222244

Entity typeother

Related Parties

1
  • filerCIK 0001364107

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 2:55 PM ET
Size
17.4 KB